Clinica Baviera(GB:0GWJ)
€54.20-0.40 (-0.73%)
GB:0GWJ
Clinica Baviera financials statements
€54.20
At close:-0.40 (-0.73%)
Clinica Baviera (0GWJ) Ratios
0 Followers
Clinica Baviera Ratios
GB:0GWJ's free cash flow for Q2 2026 was €15.23M. For the 2026 fiscal year, GB:0GWJ's free cash flow was decreased by €-6.20M and operating cash flow was €18.97M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.96 | 0.95 | 1.28 | 1.09 | 1.08 |
| Quick Ratio | 0.96 | 0.88 | 1.22 | 1.03 | 1.02 |
| Cash Ratio | 0.09 | 0.20 | 0.18 | 0.47 | 0.28 |
| Solvency Ratio | 0.48 | 0.54 | 0.61 | 0.54 | 0.53 |
| Operating Cash Flow Ratio | 1.24 | 1.24 | 1.28 | 1.30 | 1.33 |
| Short-Term Operating Cash Flow Coverage | 37.58 | 31.17 | 28.69 | 26.60 | 11.42 |
| Net Current Asset Value | € -77.41M | € -65.61M | € -28.63M | € -37.13M | € -40.49M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.28 | 0.30 | 0.27 | 0.32 | 0.39 |
| Debt-to-Equity Ratio | 0.63 | 0.65 | 0.52 | 0.71 | 0.94 |
| Debt-to-Capital Ratio | 0.39 | 0.40 | 0.34 | 0.42 | 0.49 |
| Long-Term Debt-to-Capital Ratio | 0.05 | 0.07 | 0.01 | 0.04 | 0.11 |
| Financial Leverage Ratio | 2.25 | 2.19 | 1.96 | 2.23 | 2.45 |
| Debt Service Coverage Ratio | 20.61 | 19.58 | 20.99 | 18.81 | 9.32 |
| Interest Coverage Ratio | 36.05 | 45.75 | 87.49 | 99.07 | 86.03 |
| Debt to Market Cap | 0.01 | 0.02 | 0.01 | 0.02 | 0.03 |
| Interest Debt Per Share | 4.29 | 3.97 | 2.95 | 2.96 | 3.19 |
| Net Debt to EBITDA | 0.60 | 0.68 | 0.58 | 0.51 | 0.78 |
| Profitability Margins | |||||
| Gross Profit Margin | 42.11% | 88.36% | 87.96% | 87.15% | 87.56% |
| EBIT Margin | 27.25% | 21.78% | 22.33% | 20.71% | 22.81% |
| EBITDA Margin | 35.17% | 29.74% | 29.89% | 28.30% | 30.97% |
| Operating Profit Margin | 27.25% | 21.20% | 22.24% | 20.91% | 22.83% |
| Pretax Profit Margin | 19.92% | 21.32% | 22.08% | 20.50% | 22.52% |
| Net Profit Margin | 13.94% | 15.31% | 15.99% | 14.87% | 15.86% |
| Continuous Operations Profit Margin | 14.23% | 15.67% | 16.33% | 15.22% | 16.17% |
| Net Income Per EBT | 69.97% | 71.81% | 72.44% | 72.56% | 70.41% |
| EBT Per EBIT | 73.10% | 100.57% | 99.28% | 98.04% | 98.66% |
| Return on Assets (ROA) | 16.99% | 18.97% | 20.14% | 19.67% | 20.47% |
| Return on Equity (ROE) | 38.24% | 41.48% | 39.53% | 43.83% | 50.16% |
| Return on Capital Employed (ROCE) | 44.20% | 34.53% | 37.50% | 38.04% | 39.99% |
| Return on Invested Capital (ROIC) | 29.49% | 23.70% | 25.69% | 25.86% | 25.70% |
| Return on Tangible Assets | 20.28% | 22.99% | 22.30% | 21.86% | 23.17% |
| Earnings Yield | 5.09% | 7.92% | 9.61% | 10.38% | 7.92% |
| Efficiency Ratios | |||||
| Receivables Turnover | 63.79 | 54.55 | 63.15 | 69.78 | 51.36 |
| Payables Turnover | 6.90 | 3.04 | 1.74 | 1.63 | 1.66 |
| Inventory Turnover | 0.00 | 9.31 | 10.95 | 11.80 | 11.11 |
| Fixed Asset Turnover | 2.12 | 2.14 | 2.27 | 2.31 | 2.24 |
| Asset Turnover | 1.22 | 1.24 | 1.26 | 1.32 | 1.29 |
| Working Capital Turnover Ratio | -119.61 | 53.84 | 28.04 | 63.29 | 199.59 |
| Cash Conversion Cycle | -47.16 | -74.26 | -170.17 | -187.43 | -180.59 |
| Days of Sales Outstanding | 5.72 | 6.69 | 5.78 | 5.23 | 7.11 |
| Days of Inventory Outstanding | 0.00 | 39.20 | 33.35 | 30.94 | 32.84 |
| Days of Payables Outstanding | 52.88 | 120.16 | 209.29 | 223.59 | 220.54 |
| Operating Cycle | 5.72 | 45.90 | 39.13 | 36.17 | 39.95 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 4.60 | 3.86 | 3.55 | 3.27 | 2.87 |
| Free Cash Flow Per Share | 2.79 | 2.23 | 2.16 | 2.41 | 2.23 |
| Dividend Paid and CapEx Coverage Ratio | 1.36 | 1.20 | 1.62 | 1.71 | 1.68 |
| Capital Expenditure Coverage Ratio | 2.55 | 2.37 | 2.55 | 3.80 | 4.43 |
| Operating Cash Flow Coverage Ratio | 1.11 | 0.99 | 1.22 | 1.12 | 0.91 |
| Operating Cash Flow to Sales Ratio | 0.25 | 0.24 | 0.26 | 0.27 | 0.27 |
| Free Cash Flow Yield | 5.62% | 7.14% | 9.39% | 13.83% | 10.50% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 18.90 | 12.63 | 10.41 | 9.64 | 12.62 |
| Price-to-Sales (P/S) Ratio | 2.74 | 1.93 | 1.66 | 1.43 | 2.00 |
| Price-to-Book (P/B) Ratio | 7.52 | 5.24 | 4.11 | 4.22 | 6.33 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 17.80 | 14.01 | 10.66 | 7.23 | 9.53 |
| Price-to-Operating Cash Flow Ratio | 10.81 | 8.09 | 6.48 | 5.33 | 7.38 |
| Price-to-Earnings Growth (PEG) Ratio | 2.92 | 1.07 | 0.47 | 1.25 | 0.13 |
| Enterprise Value Multiple | 8.39 | 7.18 | 6.15 | 5.58 | 7.24 |
| Enterprise Value | 890.73M | 561.18M | 413.47M | 313.13M | 387.38M |
| EV to EBITDA | 8.39 | 7.18 | 6.15 | 5.58 | 7.24 |
| EV to Sales | 2.95 | 2.14 | 1.84 | 1.58 | 2.24 |
| EV to Free Cash Flow | 19.17 | 15.48 | 11.77 | 7.96 | 10.68 |
| EV to Operating Cash Flow | 11.65 | 8.94 | 7.15 | 5.87 | 8.27 |
| Tangible Book Value Per Share | 4.26 | 3.77 | 4.60 | 3.27 | 2.44 |
| Shareholders’ Equity Per Share | 6.61 | 5.95 | 5.59 | 4.13 | 3.35 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.29 | 0.27 | 0.26 | 0.26 | 0.28 |
| Revenue Per Share | 18.13 | 16.14 | 13.82 | 12.17 | 10.59 |
| Net Income Per Share | 2.53 | 2.47 | 2.21 | 1.81 | 1.68 |
| Tax Burden | 0.70 | 0.72 | 0.72 | 0.73 | 0.70 |
| Interest Burden | 0.73 | 0.98 | 0.99 | 0.99 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.13 | 0.14 | 0.07 | 0.09 | 0.09 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.78 | 1.12 | 1.61 | 1.31 | 1.20 |
Currency in EUR

